CIIE 2025: Global Healthcare Innovation and Trade Opportunities from Shanghai

Overview

Since its debut in 2018, the China International Import Expo (CIIE) has grown into one of the world’s most influential trade events, serving as a platform for:

• International procurement

• Investment promotion

• Cultural exchange

• Open cooperation

On November 5, 2025, the 8th CIIE opened in Shanghai, welcoming:

Six Major Exhibition Zones

Zone	Focus Areas
Technical Equipment	Advanced machinery, industrial innovation
Food & Agricultural Products	Global agri‑food supply, nutrition
Trade in Services	Finance, logistics, digital services
Consumer Goods	Lifestyle, retail, luxury
Automobiles & Smart Mobility	EVs, autonomous driving, green transport
Medical Equipment & Healthcare	Devices, pharmaceuticals, nutrition, elderly care

Guest countries of honor in 2025 include UAE, Nigeria, Georgia, Sweden, and Colombia, with Thailand returning for its second time.

Spotlight: Medical Equipment & Healthcare Pavilion

• Location: Halls 1.1, 1.2, 2.2

• Size: 70,000+ m²

• Theme: Healthy China, Healthy Life

Highlights:

• Fastest CT scanner (one heartbeat cycle)

• World’s first nasal spray for acute migraine

• Weight‑management solutions (drugs, injectables, gastric balloons)

This pavilion reflects China’s rapid rise in pharmaceutical innovation, with multinationals increasing local R&D and aligning with Healthy China 2030.

Innovation at the Forefront

Innovation Area	Key Focus
Cell & Gene Therapy	Oncology, rare diseases
Tumor Immunology	Next‑gen cancer treatments
AI Drug Development	Accelerated discovery & precision medicine
Global Debuts	Multiple “world firsts” and “China firsts”

CIIE has evolved from a showcase of exhibits to a launchpad for commercialized products, bridging global pharma with China’s innovation ecosystem.

Leading Healthcare Exhibitors (Alphabetical)

Company	Highlights
Bayer	26 products, 5 global debuts; oncology, cardiovascular, ophthalmology, women’s health, gene therapy
Boehringer Ingelheim	500 m² booth; 9 new human & animal health products; RMB 5B R&D plan in China
Fosun Pharma	CAR‑T therapies, particle therapy, AI‑driven PharmAID platform
GSK	RSV vaccine, hepatitis B ASO therapy, long‑acting biologics, transformative immunotherapies
Pfizer	17 products accelerated via CIIE; oncology, rare disease, vaccines; “China 2030 Strategy”
Roche	40+ products; PDS eye implant system; new indications for immunology & oncology
Menarini	Launch of patented scar‑care silicone gel patch; expanded men’s health portfolio
Novo Nordisk	Semaglutide family; obesity management “Light Living House” immersive experience
Novartis	Radioligand therapy, xRNA, cell & gene therapies; “China Vision” strategy
Organon	Women’s health lifecycle solutions; intrauterine vacuum hemostasis system
Schwabe Group	Natural health solutions: ginkgo, lavender, hawthorn, prostate health
Yingkang Life (Haier Group)	AI‑driven biobank management, automated dialysis, 30+ innovations

Conclusion

The 8th CIIE is more than an exhibition — it is a catalyst for innovation, collaboration, and global trade. From cutting‑edge medical devices to next‑generation pharmaceuticals, the expo demonstrates how China’s vast market and international partnerships are shaping the future of healthcare and beyond.

References:

1. China International Import Expo Official Website

2. WeChat Official Report: CIIE 2025 Opening Highlights